Scholars@Duke

Introducing CCR perspectives in drug approval.

Publication ,  Journal Article
Abbruzzese, JL
Published in: Clin Cancer Res
August 1, 2011
Published version (DOI) Link to item

Duke Scholars

James Abbruzzese
Author James Abbruzzese Medicine, Medical Oncology

Published In

Clin Cancer Res

DOI

10.1158/1078-0432.CCR-11-1479

EISSN

1557-3265

Publication Date

August 1, 2011

Volume

17

Issue

15

Start / End Page

4929

Location

United States

Related Subject Headings

  • Publishing
  • Oncology & Carcinogenesis
  • Humans
  • Drug Approval
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abbruzzese, J. L. (2011). Introducing CCR perspectives in drug approval. Clin Cancer Res, 17(15), 4929. https://doi.org/10.1158/1078-0432.CCR-11-1479
Abbruzzese, James L. “Introducing CCR perspectives in drug approval.” Clin Cancer Res 17, no. 15 (August 1, 2011): 4929. https://doi.org/10.1158/1078-0432.CCR-11-1479.
Abbruzzese JL. Introducing CCR perspectives in drug approval. Clin Cancer Res. 2011 Aug 1;17(15):4929.
Abbruzzese, James L. “Introducing CCR perspectives in drug approval.” Clin Cancer Res, vol. 17, no. 15, Aug. 2011, p. 4929. Pubmed, doi:10.1158/1078-0432.CCR-11-1479.
Abbruzzese JL. Introducing CCR perspectives in drug approval. Clin Cancer Res. 2011 Aug 1;17(15):4929.

Published In

Clin Cancer Res

DOI

10.1158/1078-0432.CCR-11-1479

EISSN

1557-3265

Publication Date

August 1, 2011

Volume

17

Issue

15

Start / End Page

4929

Location

United States

Related Subject Headings

  • Publishing
  • Oncology & Carcinogenesis
  • Humans
  • Drug Approval
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis